About Anavex (AVXL)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to tr... Read more
- USD7.30
- USD7.59
- USD7.22
- USD14.44
- -26.60%
- --
- 1.14M
- 1.27M
- 685M
- 7.16
- -5.10%
Stock News
yesterday
Ongoing government shutdown and AI fears are putting the market under pressure, Jim Cramer says
CNBC
yesterday
Why a viral chart about AI-driven job destruction might actually be ‘the stupidest chart in the world’
MarketWatch
yesterday
McDonald's U.S. boss puts focus on 'value and affordability' as consumer spending splits
CNBC
yesterday
Roundtable CEO James Heckman Announces New CFO, Aly Madhavji, Visionary Investor and Blockchain Founders Fund Managing Partner, To Lead RYVYL Merger, NASDAQ Listing
Yahoo
